Abercrombie & Fitch (NYSE:ANF) Upgraded at StockNews.com
StockNews.com upgraded shares of Abercrombie & Fitch (NYSE:ANF – Free Report) from a hold rating to a buy rating in a report issued on Monday morning. A number of other analysts have also issued reports on ANF. Citigroup boosted their price objective on Abercrombie & Fitch from $33.00 to $45.00 and gave the company a […]
More Stories
AXIS Capital Holdings Limited (NYSE:AXS) Receives Average Recommendation of “Moderate Buy” from Analysts
Shares of AXIS Capital Holdings Limited (NYSE:AXS – Get Free Report) have received an average rating of “Moderate Buy” from...
AXIS Capital Holdings Limited (NYSE:AXS) Receives Average Recommendation of “Moderate Buy” from Analysts
Shares of AXIS Capital Holdings Limited (NYSE:AXS – Get Free Report) have received an average rating of “Moderate Buy” from...
Cameco Co. (TSE:CCO) Receives C$84.30 Average PT from Brokerages
Shares of Cameco Co. (TSE:CCO – Get Free Report) (NYSE:CCJ) have been assigned a consensus recommendation of “Buy” from the...
Cameco Co. (TSE:CCO) Receives C$84.30 Average PT from Brokerages
Shares of Cameco Co. (TSE:CCO – Get Free Report) (NYSE:CCJ) have been assigned a consensus recommendation of “Buy” from the...
Brokerages Set Amgen Inc. (NASDAQ:AMGN) Price Target at $318.83
Shares of Amgen Inc. (NASDAQ:AMGN – Get Free Report) have been assigned a consensus recommendation of “Hold” from the twenty-seven...
Brokerages Set Amgen Inc. (NASDAQ:AMGN) Price Target at $318.83
Shares of Amgen Inc. (NASDAQ:AMGN – Get Free Report) have been assigned a consensus recommendation of “Hold” from the twenty-seven...